Immunotherapy for the treatment of cancer

    公开(公告)号:US10517937B2

    公开(公告)日:2019-12-31

    申请号:US15503916

    申请日:2015-08-17

    Abstract: Methods for the treatment of cancer using double negative (DN) T cells are described. The DNTs may be used for the treatment of chemotherapy-resistant cancers such as recurring or relapsing acute myeloid leukemia (AML). The use of allogenic DNTs, such as those derived from healthy donors, that do not exhibit toxicity towards normal host tissues and the complications associated with graft-versus-host-disease, is also described.

Patent Agency Ranking